See up to 3 months of AIM. The 7-day demo opens the 1M and 3M ranges and puts AIM on your watchlist.
Start 7-day demoLatest AIM insider trades
About AIM ImmunoTech Inc. (AIM)
AIM ImmunoTech Inc. is an SEC registrant, filing under CIK 0000946644, classified as biological products (no diagnostic substances). It is grouped with Health Care companies on this site. A registration statement was filed on 12 December 2025. No offering has priced.
AIM Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market purchase | 6 | 125,825 | $24K |
AIM insider transactions (Form 4)
3026 Form 4 filings on record, the earliest from Nov 20, 2024, newest first.
| Traded | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Thomas K. Equels - Officer | Open-market purchase | Common Stock | 31,675 | $0.16 | $5K | |
| Thomas K. Equels - Officer | Open-market purchase | Common Stock | 31,250 | $0.16 | $5K | |
| Thomas K. Equels - Officer | Open-market purchase | Common Stock | 24,000 | $0.21 | $5K | |
| Thomas K. Equels - Officer | Open-market purchase | Common Stock | 11,000 | $0.21 | $2K | |
| Thomas K. Equels - Officer | Open-market purchase | Common Stock | 22,000 | $0.22 | $5K | |
| Thomas K. Equels - Officer | Open-market purchase | Common Stock | 5,900 | $0.22 | $1K | |
| Thomas K. Equels - Officer | Other | Common stock | 25,000 | $0.00 | - | |
| Thomas K. Equels - Officer | Other | Series G Convertible Preferred Stock | 25 | $0.00 footnote F1 | - | |
| ||||||
 David I. Chemerow - Director | Other | Common Stock | 25,000 | $0.00 | - | |
| David I. Chemerow - Director | Other | Series G Convertible Prefered Stock | 25 | $0.00 footnote F1 | - | |
| ||||||
| Thomas K. Equels - Officer | Other | Series G Convertible Preferred Stock | 25 footnote F1 | $25,000.00 | $625K | |
| Thomas K. Equels - Officer | Other | Class G Warrants | 50,000 | $0.00 footnote F3 | - | |
| ||||||
| David I. Chemerow - Director | Other | Series G Convertible Preferred Stock | 25 footnote F1 | $25,000.00 | $625K | |
| David I. Chemerow - Director | Other | Class G Warrants | 50,000 | $0.00 footnote F3 | - | |
| ||||||
| David I. Chemerow - Director | Grant or award | Common Stock | 2,800 | $1.23 | $3K | |
| Ted D. Kellner - Director | Open-market purchase | Common Stock | 1,968,504 | $0.03 | $50K | |
| William M. Mitchell - Director | Open-market purchase | Common Stock | 196,851 | $0.03 | $5K | |
| William M. Mitchell - Director | Open-market sale | Common Stock | 4,580 | $0.19 | $884 | |
| Thomas K. Equels - Officer | Open-market purchase | Common Stock | 22,727 | $0.21 | $5K | |
| Stewart Appelrouth - Director | Grant or award | Common Stock | 24,452 | $0.21 | $5K | |
| Nancy Bryan - Director | Grant or award | Common Stock | 24,452 | $0.21 | $5K | |
| William M. Mitchell - Director | Grant or award | Common Stock | 24,452 | $0.21 | $5K | |
| Stewart Appelrouth - Director | Open-market purchase | Common Stock | 1 | $0.21 | - | |
| Stewart Appelrouth - Director | Open-market purchase | Common Stock | 11,111 | $0.21 | $2K | |
| Stewart Appelrouth - Director | Grant or award | Common Stock | 22,645 | $0.23 | $5K | |
| Nancy Bryan - Director | Grant or award | Common Stock | 22,645 | $0.23 | $5K | |
| William M. Mitchell - Director | Grant or award | Common Stock | 22,645 | $0.23 | $5K | |
| Thomas K. Equels - Officer | Open-market purchase | Common Stock | 85,000 | $0.20 | $17K | |
| Stewart Appelrouth - Director | Open-market purchase | Common Stock | 81,953 | $0.19 | $16K | |
| Thomas K. Equels - Officer | Open-market purchase | Common Stock | 60,110 | $0.18 | $11K | |
Item 1.01, 3.02, 9.01
Item 1.01, 3.02, 9.01
Item 1.01, 1.02, 3.02, 9.01
Item 7.01, 9.01
AIM insider trading FAQ
What is the latest insider trade for AIM?
AIM ImmunoTech Inc. (AIM) had 6 insider filings in the last 90 days, with the most recent on 26 October 2026. The full record for AIM runs to 26 Form 4 filings, the earliest from 20 November 2024. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying AIM stock?
6 insider purchases of AIM were filed in the last 90 days, totaling $24K.
How many insiders are selling AIM stock?
No insider sales of AIM were filed in the last 90 days. 1 sale is on record for this company.
Where can I see AIM SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects AIM Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Thomas K. Equels view on EDGAR
- - Thomas K. Equels view on EDGAR
- - Thomas K. Equels view on EDGAR
- - Thomas K. Equels view on EDGAR
- - Thomas K. Equels view on EDGAR
- - Thomas K. Equels view on EDGAR
- - Thomas K. Equels view on EDGAR
- - David I. Chemerow view on EDGAR
- - Thomas K. Equels view on EDGAR
Related companies with recent insider activity
Learn more
- How to read insider buying signals
- What an open-market purchase by an insider can and cannot tell you.
- Insider activity in Health Care
- Where AIM's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow AIM with a 7-day demo
- AIM on your watchlist
- Every AIM Form 4 filing on record
- Up to 3 months of AIM price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
